UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Volltextzugriff (PDF)

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Volltextzugriff (PDF)

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0233918-e0233918

2023

Volltextzugriff (PDF)

Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient

Journal of clinical pharmacy and therapeutics, 2015-02, Vol.40 (1), p.119-120

2015

Volltextzugriff (PDF)

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Antimicrobial agents and chemotherapy, 2014-06, Vol.58 (6), p.3182-3190

2014

Volltextzugriff (PDF)

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.691-695

2012

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2091-2096

2004

Volltextzugriff (PDF)

Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

Fundamental & clinical pharmacology, 2009-08, Vol.23 (4), p.423-425

2009

Volltextzugriff (PDF)

Effect of Sofosbuvir/Daclatasvir ± Ribavirin on the Pharmacokinetics of Calcineurin Inhibitors in Liver Transplant Recipients – from the ANRS CO23 Cupilt Study

Journal of hepatology, 2016, Vol.64 (2), p.S507-S508

2016

Volltextzugriff (PDF)

Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation

Clinical gastroenterology and hepatology, 2015-11, Vol.13 (11), p.1993-2001.e2

2015

Volltextzugriff (PDF)

P1237 ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2014-04, Vol.60 (1), p.S501-S501

2014

Volltextzugriff (PDF)

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

British journal of clinical pharmacology, 2005-10, Vol.60 (4), p.390-403

2005

Volltextzugriff (PDF)

Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected Cambodians

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

In vitro effects of tacrolimus on human cytochrome P450

Fundamental & clinical pharmacology, 2002-12, Vol.16 (6), p.455-460

2002

Volltextzugriff (PDF)

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

Journal of chromatography. B, Biomedical sciences and applications, 2000-06, Vol.742 (2), p.453-458

2000

Volltextzugriff (PDF)

French 2013 guidelines for antiretroviral therapy of HIV‐1 infection in adults

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.19034-n/a

2014

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1589-1590

2002

Volltextzugriff (PDF)

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response

Journal of antimicrobial chemotherapy, 2021-01, Vol.76 (1), p.277-279

2021

Volltextzugriff (PDF)

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

Journal of antimicrobial chemotherapy, 2018-06, Vol.73 (6), p.1672-1676

2018

Volltextzugriff (PDF)

Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors

AIDS (London), 1998-12, Vol.12 (18), p.2510-2511

1998

Volltextzugriff (PDF)

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study

Clinical infectious diseases, 2014-10, Vol.59 (8), p.1177-1184

2014

Volltextzugriff (PDF)

Drug interactions with antiviral drugs

Clinical pharmacokinetics, 1996-05, Vol.30 (5), p.385-401

1996

Volltextzugriff (PDF)

Pharmacokinetic optimisation of asthma treatment

Clinical pharmacokinetics, 1994-05, Vol.26 (5), p.396-418

1994

Volltextzugriff (PDF)

1 – 25 von 335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(274)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(198)
Humans
(174)
Life Sciences & Biomedicine
(174)
Male
(108)
Biological And Medical Sciences
(106)
Medical Sciences
(105)
Female
(100)
Pharmacology. Drug Treatments
(99)
Pharmacology & Pharmacy
(97)
Adult
(94)
Hiv Infections - Drug Therapy
(84)
Infectious Diseases
(79)
Middle Aged
(73)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(68)
Antiviral Agents
(58)
Viral Diseases
(46)
Human Immunodeficiency Virus
(45)
Human Viral Diseases
(45)
Microbiology
(45)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

Effect of Sofosbuvir/Daclatasvir ± Ribavirin on the Pharmacokinetics of Calcineurin Inhibitors in Liver Transplant Recipients – from the ANRS CO23 Cupilt Study

Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation

P1237 ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected Cambodians

In vitro effects of tacrolimus on human cytochrome P450

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

French 2013 guidelines for antiretroviral therapy of HIV‐1 infection in adults

Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study

Drug interactions with antiviral drugs

Pharmacokinetic optimisation of asthma treatment

Suchergebnisse filtern